North Growth Management Ltd. Pfizer Inc Transaction History

North Growth Management Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 04, 2020	SELL	$31.75 - $37.25 $7.62 Million - $8.94 Million	-240,000 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$30.12 - $36.54 $240,960 - $292,320	-8,000 Reduced 3.23%	240,000 $7.86 Million
Q1 2020 May 08, 2020	BUY	$27.03 - $38.62 $810,900 - $1.16 Million	30,000 Added 13.76%	248,000 $8.08 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $32,490 - $42,130	1,000 Added 0.46%	218,000 $7.84 Million
Q4 2018 Feb 12, 2019	SELL	$38.47 - $43.86 $3.92 Million - $4.47 Million	-102,000 Reduced 31.97%	217,000 $9.46 Million
Q2 2018 Aug 10, 2018	BUY	$32.98 - $35.16 $1.12 Million - $1.2 Million	34,000 Added 11.93%	319,000 $11.6 Million
Q4 2017 Aug 10, 2018	BUY	$33.26 - $35.29 $9.48 Million - $10.1 Million	285,000	285,000 $10.3 Million

3,253

3.72B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of North Growth Management Ltd., based on Form 13F filings with the SEC.

Stay updated on North Growth Management Ltd. with notifications on news.